Emapalumab-Lzsg (Intravenous Route)

Name: Emapalumab-Lzsg (Intravenous Route)

US Brand Name

  1. Gamifant


Emapalumab-lzsg injection is used to treat a blood disorder called primary hemophagocytic lymphohistiocytosis (HLH) that is hard to treat (refractory), recurrent, or has worsened (progressive), or when other treatments that have been used did not work well.

This medicine is to be given only by or under the direct supervision of your doctor.

This product is available in the following dosage forms:

  • Solution


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of emapalumab-lzsg injection in the elderly.


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.